Salvatore Siena, MD [7505]
What is the role of hybrid capture-based NGS diagnostic testing for guiding precision-based treatments for colorectal and other GI cancers? (Italian)
What have research studies shown with respect to genomic alterations and clonal evolution in patients with colorectal cancer? (Italian)
How do we identify new, actionable genomic alterations for GI cancers? What is the strategy for discovering molecular targets with NGS? What is the role of EGFR, ALK, and RAS mutations in colorectal cancer and what targeted therapies are ...
What is the importance of establishing NGS-based diagnostics in clinical environments that are interested in optimizing treatments in the setting of precision-focused cancer therapeutics? (Italian)
How does the presence of EGFR, ALK, and ROS mutations affect your treatment plan in the setting of lung cancer? (Italian)